Tarsus Pharmaceuticals, Inc. TARS Common Stock, Capital Shares Reserved for Future Issuance, Employee Stock Purchase Plan
Common Stock, Capital Shares Reserved for Future Issuance, Employee Stock Purchase Plan at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept tars:CommonStockCapitalSharesReservedForFutureIssuanceEmployeeStockPurchasePlan.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s common stock, capital shares reserved for future issuance, employee stock purchase plan.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s common stock, capital shares reserved for future issuance, employee stock purchase plan?
- Tarsus Pharmaceuticals, Inc. (TARS) reported common stock, capital shares reserved for future issuance, employee stock purchase plan of 3.2M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s common stock, capital shares reserved for future issuance, employee stock purchase plan changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s common stock, capital shares reserved for future issuance, employee stock purchase plan increased by 12.5% year-over-year, from 2.9M to 3.2M.
- What does common stock, capital shares reserved for future issuance, employee stock purchase plan mean?
- This represents the number of common shares reserved specifically for issuance under an Employee Stock Purchase Plan (ESPP). It indicates the scale of equity participation offered to employees as part of their compensation package. Tracking this helps assess the company's commitment to employee retention through equity-based incentives.